SCHEMBL30062377

SCHEMBL30062377

CC(C)Oc1ccc(-c2ncc(CNc3cc(-c4cnn(C)c4)nc(C(F)(F)F)c3)s2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 3/20 0.51
▸ CYP2C9 P11712 2/20 0.51
▸ KCNH2 Q12809 1/20 0.40
▸ CLK1 P49759 1/20 0.39
▸ ABL1 P00519 1/20 0.36
▸ BCR P11274 1/20 0.36
▸ KDR P35968 6/20 0.36
▸ FGFR3 P22607 3/20 0.36
▸ MAPT P10636 4/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ TP53 P04637 2/20 0.35
▸ CYP1A2 P05177 2/20 0.34
▸ MKNK1 Q9BUB5 1/20 0.34
▸ ALPL P05186 1/20 0.34
▸ ALPI P09923 1/20 0.34
▸ KCNT1 Q5JUK3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23611234 1.00 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2CLK1ABL1
SCHEMBL23611535 0.85 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2ABL1BCR
SCHEMBL30060450 0.85 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2ABL1BCR
SCHEMBL23627706 0.85 CLK1 (0.39) CYP2C19CYP2C9CLK1ABL1BCR
SCHEMBL21612040 0.84 CYP2C19 (0.61) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL23611318 0.84 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL30062257 0.84 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL30060458 0.83 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL23611317 0.83 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2
SCHEMBL31694535 0.83 CYP2C19 (0.50) CYP2C19CYP2C9KCNH2MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085057-A1 NOVEL PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2022-11-09 — — EP disclosed
Send feedback